Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T F Pajak

Showing results (61-70 of 144) with videos related to

Pageof 15
Sort By:
Cancer|January 1, 1980
A randomized combined modality trial in small cell carcinoma of the lung: comparison of combination chemotherapy-radiation therapy versus cyclophosphamide-radiation therapy effects of maintenance chemotherapy and prophylactiv whole brain irradiationL H Maurer, M Tulloh, R B Weiss, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1997
Recursive partitioning analysis of 1592 patients on four Radiation Therapy Oncology Group studies in inoperable non-small cell lung cancerC Scott, W T Sause, R Byhardt, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Dose intensity of radiation therapy in non-small cell carcinoma of the lung: a review of RTOG data and strategiesJ D Cox, W T Sause, R W Byhardt, et al.
Annals of Internal Medicine|June 1, 1982
Diffuse malignant mesothelioma. Prospective evaluation of 69 patientsA P Chahinian, T F Pajak, J F Holland, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 1994
PSA confirmation of cure at 10 years of T1B, T2, N0, M0 prostate cancer patients treated in RTOG protocol 7706 with external beam irradiationG E Hanks, C A Perez, M Kozar, et al.
JAMA|August 2, 1995
Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20M Rotman, T F Pajak, K Choi, et al.
Blood|July 1, 1979
Improved survival of increased-risk myeloma patients on combined triple-alkylating-agent therapy: a study of the CALGBJ B Harley, T F Pajak, O R McIntyre, et al.
Journal of Surgical Oncology|March 1, 1994
Chemotherapy as predictor of complianceJ R Jacobs, R R Casiano, D E Schuller, et al.
Journal of Neuro-Oncology|January 1, 1985
Survival and prognosis of patients with astrocytoma with atypical or anaplastic featuresD F Nelson, J S Nelson, D R Davis, et al.
Cancer Treatment Reports|February 1, 1979
Procarbazine, vinblastine, and actinomycin D in stage III and IV melanoma with or without methanol-extracted residue of Bacillus Calmette-GuérinJ E Kostinas, L A Leone, J Cuttner, et al.
Pageof 15

Showing results (61-70 of 144) with videos related to

Sort By:
Pageof 15
Cancer|January 1, 1980
A randomized combined modality trial in small cell carcinoma of the lung: comparison of combination chemotherapy-radiation therapy versus cyclophosphamide-radiation therapy effects of maintenance chemotherapy and prophylactiv whole brain irradiationL H Maurer, M Tulloh, R B Weiss, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1997
Recursive partitioning analysis of 1592 patients on four Radiation Therapy Oncology Group studies in inoperable non-small cell lung cancerC Scott, W T Sause, R Byhardt, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Dose intensity of radiation therapy in non-small cell carcinoma of the lung: a review of RTOG data and strategiesJ D Cox, W T Sause, R W Byhardt, et al.
Annals of Internal Medicine|June 1, 1982
Diffuse malignant mesothelioma. Prospective evaluation of 69 patientsA P Chahinian, T F Pajak, J F Holland, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 1994
PSA confirmation of cure at 10 years of T1B, T2, N0, M0 prostate cancer patients treated in RTOG protocol 7706 with external beam irradiationG E Hanks, C A Perez, M Kozar, et al.
JAMA|August 2, 1995
Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20M Rotman, T F Pajak, K Choi, et al.
Blood|July 1, 1979
Improved survival of increased-risk myeloma patients on combined triple-alkylating-agent therapy: a study of the CALGBJ B Harley, T F Pajak, O R McIntyre, et al.
Journal of Surgical Oncology|March 1, 1994
Chemotherapy as predictor of complianceJ R Jacobs, R R Casiano, D E Schuller, et al.
Journal of Neuro-Oncology|January 1, 1985
Survival and prognosis of patients with astrocytoma with atypical or anaplastic featuresD F Nelson, J S Nelson, D R Davis, et al.
Cancer Treatment Reports|February 1, 1979
Procarbazine, vinblastine, and actinomycin D in stage III and IV melanoma with or without methanol-extracted residue of Bacillus Calmette-GuérinJ E Kostinas, L A Leone, J Cuttner, et al.
Pageof 15